Beecken Petty O’Keefe & Company (BPOC) has announced it will sell Cranial Technologies to Eurazeo.

Cranial Technologies, based in Tempe, Ariz., is a developer, manufacturer and provider of custom cranial orthotics for treating infants with plagiocephaly. Founded in 1986, the company manufactures the DOC Band, a custom cranial orthotic.

BPOC, based in Chicago, seeks control and minority equity investments in middle market companies exclusively within the healthcare industry. Founded in 1996, the firm pursues companies generating at least $10 million in revenue through a wide range of investments. Within healthcare, the firm targets companies in the provider services, life sciences/pharmaceutical and non-reimbursement industries.

Eurazeo, based in Paris, France, is a global investment company.

Terms of the sale were not disclosed.

York Private Equity has made a strategic growth investment in APT Healthcare, according to a news release.

APT Healthcare, based in Glen Burnie, Md., is an outpatient physical therapy group. Founded in 2002, the company services the Mid-Atlantic region with nearly 60 reported locations in Maryland, Virginia and Washington, D.C.

York Private Equity, based in New York, is the private investing arm of York Capital Management. The division primarily targets control investments in middle market businesses.  Since its inception in 2008, York Private Equity states it has completed more than 50 investments.

Terms of the investment were not disclosed.

Francisco Partners will acquire data and analytics assets from IBM that are currently part of its Watson Health business, according to a news release.

Assets that will be acquired by Francisco Partners reportedly include Health Insights, MarketScan, Clinical Development, Social Program Management, Micromedex and imaging software offerings.

Francisco Partners, with its U.S. headquarters in San Francisco, is a private equity firm that specializes in investments in technology and technology-enabled businesses.

Terms of the deal were not disclosed. The transaction is expected to close in the second quarter of this year.

Nautic Partners has made a strategic growth investment in SPS Health, according to a news release.

SPS, based in Milwaukee, offers a portfolio of solutions, including formulary management, on-demand pharmacy and benefit administration, to pharmacies and pharmacy benefit managers. Services are provided through SPS’s three companies: LithiaRx, Trinity Healthcare Solutions and StatimRx.

Nautic, based in Providence, R.I., is a middle market private equity firm focused on investments in healthcare and a few other sectors. The firm prefers to make $50 million to $400 million-plus equity commitments in a variety of growth, consolidation and buyout opportunities of North American companies with enterprise values from $100 million to $1 billion and more.

Terms of the investment were not disclosed.

Great Point Partners (GPP) has acquired Performance Cell Manufacturing (PCM), according to a news release.

PCM, based in San Diego and founded in 2002, is a contract development and manufacturing organization of cell therapy products for biopharmaceutical companies.

As part of the transaction, PCM is changing its name to Cellipont Bioservices.

GPP, based in Greenwich, Conn., is a private investment firm focused on the healthcare industry. Founded in 2003, the firm targets investments in biopharmaceutical supply chain services and products; healthcare services; healthcare information technology-enabled services; and medical devices and diagnostics in businesses operating in the United States, Canada and Western Europe. GPP pursues companies generating between $10 million and $100 million of revenue and $2 million to $12 million of EBITDA, with equity investments ranging from $7 million to $50 million.

Terms of the acquisition were not disclosed

Lee Equity Partners has announced it has invested in Therapy Partner Solutions (TPS).

TPS, based in Fernandina Beach, Fla., delivers physical therapy services across three divisions: clinic partnership, management services and performance solutions. Founded in 2017, TPS states that its family of companies has offices in nine states and services clients in nearly all states.

Lee Equity Partners is a New York-based private equity firm that focuses on control buyouts and growth capital financings in the middle market. Founded in 2006, the firm prefers to make more substantial investments in several sectors, including healthcare.

Terms of the investment were not disclosed.

One Equity Partners (OEP) has announced it has completed a strategic investment of InfuCare Rx

InfuCare Rx, based in Fairfield, N.J., is a national provider of specialty infusion therapies and comprehensive clinical therapy management services to patients with complex conditions. Founded in 2015, the company reports servicing more than 4,000 patients across 43 states.

OEP, based in New York, is a middle market private equity firm focused on healthcare and a few other sectors in North America and Europe. Founded in 2001 and spun out of J.P. Morgan in 2015, OEP seeks control-oriented investments with flexible structure in companies with revenue between $100 million and $800 million and EBITDA of $10 million to $70 million.

Terms of the transaction were not disclosed.

Nordic Capital has made a minority equity investment in RLDatix, according to a news release.

RLDatix, with its U.S. offices in Chicago and Fairfax, Va., is a provider of governance, risk and compliance solutions for healthcare. The company reports more than 5,000 customers in more than 20 countries.

Nordic, with its U.S. office in New York, is a private equity firm that focuses on healthcare and several other sectors. Founded in 1989, the firm reports it has completed more than 120 investments.

Existing investors Five Arrows and TA Associates will maintain their majority equity stake in RLDatix.

Terms of the transaction were not disclosed.

WindRose Health Investors has announced it has completed the recapitalization of Terrapin Pharmacy.

Terrapin, based in Annapolis, Md., is a specialized pharmacy primarily serving individuals diagnosed with severe and persistent mental illnesses in the Mid-Atlantic region. Founded in 2005, the company states it serves skilled nursing and rehabilitation facilities, assisted living facilities and retirement communities.

WindRose, based in New York, pursues control equity investments in healthcare companies. Founded in 2000, the firm invests in a broad range of industry segments, including outsourced services to payors and health systems, technology-enabled services, healthcare providers and value-added distribution.

Terms of the transaction were not disclosed.

Thomas H. Lee Partners (THL) has completed a strategic investment in Smile Doctors, according to a news release.

Smile Doctors, based in Georgetown, Texas, is an orthodontics-focused dental support organization. The company reports operating more than 295 locations in 25 states.

THL, based in Boston, is a private equity firm investing in middle market growth companies in three sectors, including healthcare. Founded in 1974, the firm typically targets companies with enterprise values between $250 million and $2.5 billion.

THL is investing in Smile Doctors alongside existing sponsor Linden Capital Partners in an equal partnership.

Linden, based in Chicago, is a private equity firm focused exclusively on the healthcare industry. Founded in 2004, the firm pursues acquisition opportunities across the healthcare industry, including services, products and distribution companies, and prefers to make more substantial investments from a dollars perspective.

Terms of the investment were not disclosed.